Cardiovascular autonomic failure in hereditary transthyretin amyloidosis and TTR carriers is an early and progressive disease marker.
Chiaro G, Stancanelli C, Koay S, Vichayanrat E, Sander L, Ingle GT, McNamara P, Carr AS, Wechalekar AD, Whelan CJ, Gillmore JD, Hawkins PN, Reilly MM, Mathias CJ, Iodice V.
Chiaro G, et al. Among authors: carr as.
Clin Auton Res. 2024 May 20. doi: 10.1007/s10286-024-01038-z. Online ahead of print.
Clin Auton Res. 2024.
PMID: 38769233